Literature DB >> 1592390

Life history of cutaneous vascular lesions in Sneddon's syndrome.

B Zelger1, N Sepp, K W Schmid, H Hintner, G Klein, P O Fritsch.   

Abstract

Sneddon's syndrome is a potentially fatal arterio-occlusive disorder characterized by generalized livedo racemosa and cerebrovascular lesions. Skin biopsies often fail to yield diagnostic arterial lesions. In the present series, affected vessels were found in skin biopsies from 12 of 15 patients with Sneddon's syndrome. Selection of the correct biopsy site (seemingly uninvolved skin at the center of a livedo racemosa area), adequate biopsy size (1 to 2 cm), and serial sections are essential for the detection of relevant vascular pathology. Only small to medium-sized arteries of the dermis-subcutis boundary were found to be involved. Lesions follow a distinct course. The initial stage displays partial detachment of endothelial cells, adhesion of mononuclear cells interspersed with fibrin ("endothelitis"), a marked edema of the surrounding connective tissue with numerous dilated capillaries, and a predominantly lymphohistiocytic infiltrate with polymorphonuclear leukocytes. In the early phase a sponge-like plug is formed from mononuclear cells, fibrin, and red blood cells, leading to partial to complete obstruction. A perivascular inflammatory infiltrate, devoid of polymorphonuclear leukocytes, is located around affected arteries; in the adventitia of the occluded vessel, a very regular corona of dilated capillaries appears that is continuous with more peripheral dilated and branching vessels. Organization of the occluding plug ensues in the intermediate stage by "subendothelial cell proliferation," most likely due to immigrating smooth muscle cells. In the final stage, the occluding artery undergoes fibrosis, shrinkage, and atrophy.

Entities:  

Mesh:

Year:  1992        PMID: 1592390     DOI: 10.1016/0046-8177(92)90323-u

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

Review 1.  Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy?

Authors:  Salma Siddique; Jessie Risse; Guillaume Canaud; Stéphane Zuily
Journal:  Curr Rheumatol Rep       Date:  2017-09-04       Impact factor: 4.592

2.  Familial Sneddon's syndrome.

Authors:  A Lossos; T Ben-Hur; Z Ben-Nariah; C Enk; M Gomori; D Soffer
Journal:  J Neurol       Date:  1995-02       Impact factor: 4.849

Review 3.  Familial inflammatory Sneddon's syndrome-case report and review of the literature.

Authors:  M Szmyrka-Kaczmarek; T Daikeler; D Benz; I Koetter
Journal:  Clin Rheumatol       Date:  2004-08-31       Impact factor: 2.980

Review 4.  Sneddon's syndrome: a comprehensive review of the literature.

Authors:  Shengjun Wu; Ziqi Xu; Hui Liang
Journal:  Orphanet J Rare Dis       Date:  2014-12-31       Impact factor: 4.123

Review 5.  Bar Code Reader - an algorithmic approach to cutaneous occluding vasculopathies? part II medium vessel vasculopathies.

Authors:  Gudrun Ratzinger; Bettina G Zelger; Bernhard W Zelger
Journal:  J Dtsch Dermatol Ges       Date:  2019-11       Impact factor: 5.584

6.  Coexistence of scleromyxedema and Sneddon syndrome.

Authors:  Antonio Furci; Micol Del Giglio; Francesco Bellinato; Chiara Colato; Giampiero Girolomoni
Journal:  JAAD Case Rep       Date:  2021-03-20

Review 7.  The Relevance of Skin Biopsies in General Internal Medicine: Facts and Myths.

Authors:  Sophie Bailleux; Patrick Collins; Arjen F Nikkels
Journal:  Dermatol Ther (Heidelb)       Date:  2022-04-17

8.  Long-term follow-up of early-onset Sneddon syndrome: A case report.

Authors:  Stephan Forchhammer; Gisela Metzler; Kamran Ghoreschi
Journal:  JAAD Case Rep       Date:  2018-10-03

9.  A NOTCH3 homozygous nonsense mutation in familial Sneddon syndrome with pediatric stroke.

Authors:  Elli Katharine Greisenegger; Sara Llufriu; Angel Chamorro; Alvaro Cervera; Adriano Jimenez-Escrig; Klemens Rappersberger; Wolfgang Marik; Stefan Greisenegger; Elisabeth Stögmann; Tamara Kopp; Tim M Strom; Jörg Henes; Anne Joutel; Alexander Zimprich
Journal:  J Neurol       Date:  2020-09-26       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.